← FDA DRUG APPROVALS

FDA ANDA · ANDA216328

OFLOXACIN

Sponsor: SOMERSET THERAPS LLC

APPLICATION
ANDA216328
TYPE
ANDA
ORIGINAL APPROVAL
2024-10-15
LATEST ACTION
2024-10-15
ROUTE
AURICULAR (OTIC), OTIC
DOSAGE FORM
SOLUTION/DROPS
MARKETING STATUS
Prescription

Products

OFLOXACINPrescription
OFLOXACIN 0.3% · SOLUTION/DROPS · OTIC

Approval history

2024-10-15UNKNOWN · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →